Cannabis Related Content

Nick Morland, Tenacious Labs CEO, All-Party Parliamentary Group for CBD Products Secretariat, Jersey Cannabis Services Advisory Board Chair, writes about the UK Cannabis Industry – could this be the next Scottish Whisky?

Research finds that labels on weed often fail to adequately reflect products' chemical make-up and components of the weed strain.

One million homes will be given cannabis plants across Thailand, to mark the legalisation and attract foreign tourists – to be used for ‘medicinal purposes’ only.

Senior Associate David Hardstaff and Partner John Binns of BCL Solicitors explore shifting sands in the UK CBD industry.

Recreational and medicinal legalised marijuana can reduce demand for prescription drugs, via state Medicaid programmes.

Dr Stephen Barnhill MD, CEO of Apollon Formularies Plc, examines medical cannabis and the future of cancer treatments across the UK and the European healthcare sectors.

Suzette Smiley-Jewell, PhD & Pamela J. Lein, PhD from the University of California, Davis, explore the extent to which animal CBD products are safe

Prof Trevor M Jones charts the priorities for research and development, production and distribution of medical cannabis-based treatments

Senior Associate, David Hardstaff and Partner, John Binns of BCL Solicitors LLP, explore the UK’s doomed Medical Cannabis (Access) Bill

Research demonstrates the ability to prevent COVID-19 from entering human cells through cannabinoid acids binding to a SARS-CoV-2 protein, blocking infection from the virus.

CBD has wide-ranging benefits, but what about its effects on depression? Here, we find out what the research shows from Oils by Simpson of 2012.

Recent cannabis use has been shown to affect extremes of nightly sleep duration, being either less than six hours or more than nine hours, with more intense patterns among heavier users.

At OilsBySimpson we provide the highest quality of organic full-spectrum cannabis oil products, and the best customer service.

A study finds that perinatal women are increasingly using cannabis due to the absence of consistent counselling from healthcare professionals.

BCL Solicitors LLP ask if a new report should put a spring in the step of UK businesses with an interest in medicinal cannabis and cannabidiol (CBD).

Delve into the story of Kevin Simpson, who used Cannabidiol (CBD) to treat Type 2 Diabetes.

CBD has shown benefits for many health conditions, including arthritis. Here’s what the research shows.

Arun Swaminathan MD, Assistant Professor of Neurology and Epilepsy at the University of Nebraska Medical Center, details the expanding scope of cannabinoids in epilepsy.

John Binns, Partner at BCL Solicitors LLP says it’s high stakes when it comes to the UK finally clearing a pathway towards cannabis investments.

Here, Evolve Ltd’s Managing Director, Christopher Busuttil Delbridge, takes us progressively deeper into what it takes to ensure regulatory compliance for Medical Cannabis.